Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Biopharmaceutical Company for Brain Health Disorders - Sage |
Description | Seeing the brain differently makes a world of Sage Therapeutics is a biopharmaceutical company developing novel therapies for brain health disorders with Depression, Neurology and Neuropsychiatric franchise |
Keywords | N/A |
WebSite | sagerx.com |
Host IP | 165.160.13.20 |
Location | United States |
Site | Rank |
US$99,994,361
Last updated: 2023-05-01 06:56:43
sagerx.com has Semrush global rank of 105,849. sagerx.com has an estimated worth of US$ 99,994,361, based on its estimated Ads revenue. sagerx.com receives approximately 11,537,811 unique visitors each day. Its web server is located in United States, with IP address 165.160.13.20. According to SiteAdvisor, sagerx.com is safe to visit. |
Purchase/Sale Value | US$99,994,361 |
Daily Ads Revenue | US$92,303 |
Monthly Ads Revenue | US$2,769,075 |
Yearly Ads Revenue | US$33,228,896 |
Daily Unique Visitors | 769,188 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
sagerx.com. | A | 14400 | IP: 165.160.13.20 |
sagerx.com. | A | 14400 | IP: 165.160.15.20 |
sagerx.com. | NS | 14400 | NS Record: dns2.cscdns.net. |
sagerx.com. | NS | 14400 | NS Record: dns1.cscdns.net. |
sagerx.com. | MX | 14400 | MX Record: 10 us-smtp-inbound-2.mimecast.com. |
sagerx.com. | MX | 14400 | MX Record: 10 us-smtp-inbound-1.mimecast.com. |
sagerx.com. | TXT | 14400 | TXT Record: hes=8caf98ab055974a50834c32afcf862c3 |
sagerx.com. | TXT | 14400 | TXT Record: miro-verification=4ec8443c3b12d11c2864c3b9938c133dae6aa431 |
sagerx.com. | TXT | 14400 | TXT Record: v=spf1 include:_netblocks.mimecast.com include:spf.emailsignatures365.com ~all |
sagerx.com. | TXT | 14400 | TXT Record: 0ed1fe018af56628479d7b46b8bd7ed16fbf44029d |
sagerx.com. | TXT | 14400 | TXT Record: MS=ms41395445 |
sagerx.com. | TXT | 3600 | TXT Record: adobe-idp-site-verification=2a8379fe11ac3a095da3bc94e336614d69f1811456a68cb59ccc3e9aafad7d1e |
sagerx.com. | TXT | 14400 | TXT Record: apple-domain-verification=iS21BnaxSQ65FrvA |
sagerx.com. | TXT | 14400 | TXT Record: citrix-verification-code=43170b52-8504-4d87-93ab-621128af63ce |
sagerx.com. | TXT | 300 | TXT Record: cloudhealth=d7a42db4-77ae-4177-a360-92b1d5f87052 |
sagerx.com. | TXT | 300 | TXT Record: docusign=843d1918-0484-44dc-a153-ac98375c95cf |
sagerx.com. | TXT | 14400 | TXT Record: docusign=acc815d3-aa4d-4f42-a5d1-575f2302631f |
sagerx.com. | TXT | 300 | TXT Record: google-site-verification=6PzjIf17Cyssm5eUY9YnuCPAkIEkFrDTnzCsXzMHw1o |
sagerx.com. | TXT | 300 | TXT Record: google-site-verification=bx1kuG8k668a17yOFv9fnVJ71GKfjfoTp6UhTM3vgwA |
Seeing the brain differently makes a world of difference Learn More About Our Approach "/>--> Previous Next Previous Next INSIGHTS & POINT OF VIEW Sage Thoughts View More At the Crossroads of Innovation and Policy, People Suffer LEARN MORE Brain Works LEARN MORE Conversations: "A Clinical Perspective on Sage Science – from Bench to Patient" LEARN MORE News The latest from Sage press releases Sage Therapeutics to Report First Quarter 2023 Financial Results on Tuesday, May 2, 2023 events Sage Therapeutics Q1 2023 Financial Results Conference Call sage thoughts At Sage, we believe we see possibilities where others do not and are working to find potential ways to treat people with brain health disorders. Sage Thoughts provides insights and points of view about brain health. See All News PATIENTS & CARE PARTNERS Putting patients and their families first We are rethinking care and how it is delivered to help patients and families impacted by brain health disorders. Postpartum |
HTTP/1.1 301 Moved Permanently Date: Sat, 23 Oct 2021 22:11:19 GMT Location: https://www.sagerx.com Content-Length: 0 X-ORACLE-DMS-ECID: 639cdd3c-879f-4d77-90af-2726758d541a-4ed2a269 X-ORACLE-DMS-RID: 0 HTTP/2 200 content-type: text/html; charset=utf-8 content-length: 76054 last-modified: Tue, 19 Oct 2021 11:09:41 GMT x-amz-version-id: 03.cCgxfgX2BhlPOgp3P3fFFi3GNackQ server: AmazonS3 x-content-type-options: nosniff strict-transport-security: max-age=31536000 x-xss-protection: 1; mode=block x-frame-options: SAMEORIGIN content-security-policy: frame-ancestors 'self'; date: Sat, 23 Oct 2021 21:24:51 GMT etag: "bd4c356ad856decc664afd31ccdad493" vary: Accept-Encoding x-cache: Hit from cloudfront via: 1.1 3765ff5ab7256fdbff87302f60a6d801.cloudfront.net (CloudFront) x-amz-cf-pop: ORD50-C1 x-amz-cf-id: KGDYUgJvp3VZQM5Ym_oyEoPQqP9LNBYYGKutBwgvtQbvnQd9cv3xiA== age: 2789 |
Domain Name: SAGERX.COM Registry Domain ID: 1644567210_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2019-04-16T20:32:51Z Creation Date: 2011-03-09T20:32:34Z Registry Expiry Date: 2023-03-09T20:32:34Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited Domain Status: serverTransferProhibited https://icann.org/epp#serverTransferProhibited Domain Status: serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited Name Server: DNS1.CSCDNS.NET Name Server: DNS2.CSCDNS.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-12T07:26:47Z <<< |